EpilepsyGTx
About:
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.
Website: https://www.epilepsygtx.com/
Top Investors: UCL Technology Fund, HTH
Description:
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
Total Funding Amount:
$10M
Headquarters Location:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2021-01-01
Contact Email:
info(AT)epilepsygtx.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-06-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai